GlassScriptPhysician profile
Gary J Rosenbaum
NPI 1922141423
$16,846.38
in general payments reported to CMS, 2019-2025
13 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $108 · 2021: $270 · 2022: $441 · 2023: $423 · 2024: $1,175 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,069 · Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,068.88 |
| Food and Beverage | $1,256.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12,549.07 | 2019-2022 | |
| Abbvie INC. | $2,846.36 | 2021-2025 | Alloderm |
| Sientra, INC. | $446.59 | 2021-2022 | |
| Mentor Worldwide LLC | $353.70 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $222.01 | 2019-2023 | |
| Merz North America, INC. | $146.15 | 2019 | |
| Tela Bio, INC. | $105.84 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Zimmer Biomet Holdings, INC. | $40.26 | 2019 | |
| Solventum Corporation | $36.41 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Motiva USA, LLC | $31.55 | 2025 | |
| Kci USA, INC. | $27.25 | 2022 | |
| Coopersurgical, INC. | $24.28 | 2025 | Onetrac Lx |
| Davol INC. | $16.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.